Hrt Financial LP Orchard Therapeutics PLC Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $10,915 - $20,271	-25,989 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.7 - $1.51 $18,192 - $39,243	25,989 New	25,989 $18,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $23,784 - $45,723	-20,504 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $45,928 - $87,962	20,504 New	20,504 $47,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $101,676 - $167,454	-23,161 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $101,676 - $210,301	23,161 New	23,161 $168,000
Q4 2020 Feb 16, 2021	SELL	$3.86 - $5.07 $67,017 - $88,025	-17,362 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.11 - $6.45 $71,357 - $111,984	17,362 New	17,362 $71,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.